Kathy Boyd David
The Journal of Nuclear Cardiology has just released a new JNC Compendium that provides a clear, up-to-date summary of what is known about cardiac amyloidosis as well as insights on…
The Phase III REVEAL study met its primary endpoints demonstrating sensitivity and specificity of the PET/CT investigational radiotracer I-124 evuzamitide for diagnosing cardiac amyloidosis based on visual scan interpretation, according…
Episode 13 of JNC CardioConnect highlights the results of the landmark AURORA sub-study, which found F-18 flurpiridaz PET significantly outperformed traditional SPECT imaging in detecting obstructive coronary artery disease in…
Etienne Montagut, president and CEO of PharmaLogic, will present at ASNC’s upcoming congressional briefing on Capitol Hill. PharmaLogic is a global contract development and manufacturing organization specializing in diagnostic and…
“This is an exciting time for all of us in nuclear cardiology, as evidenced by the innovative science and intriguing cases that our community will be presenting at ASNC2026 in…
ASNC joined the American Academy of Family Physicians and 22 other national organizations in a letter to Secretary of State Marco Rubio and Secretary of Homeland Security Markwayne Mullin urging…
” … [I]t’s important to go out there and find these patients, diagnose them and treat them. It’s been a remarkable transformation in a field that, less than 10 years…
“As coronary artery disease becomes more diffuse and functionally mediated, the diagnostic focus must shift accordingly. In this setting, the value of functional imaging lies less in visualization and more…